ACE2 activators (Pulmokine/University of Florida)

N/A

Report date: 2025/03/17 09:43:14
NME

Base Information

Drug NameACE2 activators (Pulmokine/University of Florida)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme 2 stimulants
TargetsAngiotensin-converting enzyme 2
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPulmokine Inc
China Registration ClassN/A

Develop Information

Active CompaniesPulmokine IncUniversity Of Florida
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A